These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 3358010
1. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice. Roy D, Snodgrass WR. Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010 [Abstract] [Full Text] [Related]
2. Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes. Roy D, Snodgrass WR. J Pharmacol Exp Ther; 1990 Mar; 252(3):895-900. PubMed ID: 2319474 [Abstract] [Full Text] [Related]
3. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450. Lettéron P, Fouin-Fortunet H, Tinel M, Danan G, Belghiti J, Pessayre D. J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179 [Abstract] [Full Text] [Related]
9. Covalent binding of procainamide in vitro and in vivo to hepatic protein in mice. Freeman RW, Uetrecht JP, Woosley RL, Oates JA, Harbison RD. Drug Metab Dispos; 1981 Jun; 9(3):188-92. PubMed ID: 6166442 [Abstract] [Full Text] [Related]
11. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Marinello AJ, Bansal SK, Paul B, Koser PL, Love J, Struck RF, Gurtoo HL. Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709 [Abstract] [Full Text] [Related]
12. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation. Munns AJ, De Voss JJ, Hooper WD, Dickinson RG, Gillam EM. Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589 [Abstract] [Full Text] [Related]
13. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM, Oudshoorn MJ, Van Ommen B, Haenen GR, Van Bladeren PJ. Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226 [Abstract] [Full Text] [Related]
14. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. Berson A, Wolf C, Chachaty C, Fisch C, Fau D, Eugene D, Loeper J, Gauthier JC, Beaune P, Pompon D. J Pharmacol Exp Ther; 1993 Apr; 265(1):366-72. PubMed ID: 8386241 [Abstract] [Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
18. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein. Masubuchi Y, Araki J, Narimatsu S, Suzuki T. Biochem Pharmacol; 1992 Jun 23; 43(12):2551-7. PubMed ID: 1632813 [Abstract] [Full Text] [Related]
19. Genetic differences in phenytoin pharmacokinetics. In vivo clearance and in vitro metabolism among inbred strains of mice. Atlas SA, Zweier JL, Nebert DW. Dev Pharmacol Ther; 1980 Jun 23; 1(5):281-304. PubMed ID: 7438974 [Abstract] [Full Text] [Related]
20. Inactivation of cytochrome P-450 by the drug methoxsalen. Fouin-Fortunet H, Tinel M, Descatoire V, Letteron P, Larrey D, Geneve J, Pessayre D. J Pharmacol Exp Ther; 1986 Jan 23; 236(1):237-47. PubMed ID: 3941395 [Abstract] [Full Text] [Related] Page: [Next] [New Search]